Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5672_Библиотеки_им_академика_М_И_Перельмана
.pdf
424
Metals in Medicine, Volume 2
FIGURE 13.11
https://t.me/med1917

Role of Gold Nanoparticles as Novel Agents for Cancer Diagnosis and Therapy
425
technologies have been applied in numerous research over the past ten years
-
array systems.
71,72
based predictors is not as good as previously assumed, even though enormous
-
73
A genome analysis
FIGURE 13.12 Protein-protein interactions.
https://t.me/med1917

426
Metals in Medicine, Volume 2
74
We need to learn more about the mysterious biomolecular characteristics
circumstances produce premalignant cells We need to use a study strategy
that incorporates the many components (molecular, cellular, and supracel-
TABLE 13.3 Gene Enrichment.
Enrichment
FDR
Number
of genes
Pathway
genes
Fold
enrichment
Pathways (click for details)
2 3 760.4
3 6 570.3 Basement membrane
2 5 456.2 Hydroxylation
3 11 311.1 Basement membrane, and G2F domain
4 17 268.4 Basement membrane, and hemidesmosome
2 10 228.1 Collagen trimer
2 13 175.5 Proteoglycan
3 22 155.5 Extracellular matrix
4 37 123.3 Basement membrane, and glycoprotein
complex
3 30 114.1
3 46 74.4 Collagen-containing extracellular matrix
4 77 59.2
3 61 56.1
4 90 50.7 Mixed, including m band, and basement
membrane
4 162 28.2
4 233 19.6 Supramolecular polymer
4 236 19.3
process
5 431 13.2 Supramolecular complex
https://t.me/med1917

Role of Gold Nanoparticles as Novel Agents for Cancer Diagnosis and Therapy
427
research indicates that this milieu is crucial in promoting and maintaining
cancer and aberrant cell development.
75
-
tion.
76,77
78
75
76,77
78
By
-
regulation, DNA repair, and signal transduction may become silenced as a
79,80
In these conditions,
an undiscovered process causes the stroma and epithelial cells to co-evolve
81,82
83–85
Actually, estrogens and progesterone can both
79
https://t.me/med1917

428
Metals in Medicine, Volume 2
-
87
-
-
several concerns regarding the study designs, data collecting and standard-
is increased as sometimes many more genes are being examined than there
are patients.
https://t.me/med1917

Role of Gold Nanoparticles as Novel Agents for Cancer Diagnosis and Therapy
429
-
13.11 CONCLUSION
-
include targeting via one or more ligands, therapy by their administration
and applications. For instance, both molecular imaging and targeted therapy
-
tionalities may be developed.
host stroma molecular data and tumor gene expression (radiation, surgery,
excretion, metabolism, and pharmacodynamics in in vivo animal models is
https://t.me/med1917

430
Metals in Medicine, Volume 2
KEYWORDS
• nanoparticles
• cancer
• diagnosis
• gold nanoparticles
REFERENCES
Medicine (Baltimore) 2019, 98 (18).
Materials for Biomedical Engineering
Elsevier, 2019, pp 211–240.
Applications. J. King Saud Univ. Sci. 2021, 33 (7), 101560.
Biomed. Opt. Express 2019, 10 (7), 3152–3182.
Properties. Adv. Colloid Interface Sci. 2019, 271, 101989.
Nanocarriers for Drug-Targeting Brain Tumors
KONA Powder Part. J. 2020,
37, 224–232.
Eco-Friendly Approach. Chemistry 2022, 4 (2), 345–369.
Int. J. Nanomater. Nanotechnol. Nanomed. 2021, 7 (1), 019–025.
Properties. Adv. Colloid Interface Sci. 2019, 271, 101989.
Seminars in Cancer Biology
Front. Biosci. (Landmark
Ed) 2014, 19 (8), 1320–1344.
Front. Microbiol. 2021,
12, 633090.
https://t.me/med1917

Role of Gold Nanoparticles as Novel Agents for Cancer Diagnosis and Therapy
431
Chemosphere 2022, 287, 132271.
J. King Saud Univ. Sci. 2022, 34 (4), 101939.
J.
Nanomater. 2021, 2021.
Proc. Natl. Acad. Sci. 2016, 113 (9),
E1142–E1151.
Mol. Clin. Oncol.
2014, 2 (6), 904–908.
Nat. Commun. 2018, 9 (1), 1–2.
Progress and Challenges. Nanosc. Res. Lett. 2021, 16 (1), 1–21.
Sci. Rep. 2018, 8 (1), 1–2.
Mol. Med. Rep. 2020, 22 (6), 4475–4484.
in Advanced Biomedical Applications. Nanosc. Adv. 2020, 2 (9), 3764–3787.
J. Mod. Nanotechnol. 2021.
Polymers 2018, 10 (9), 961.
Electroanalysis 2018, 30 (12), 2861–2868.
Cancer Cells. Photodiagn. Photodyn. Ther. 2018, 23, 295–305.
Multicore Fiber Sensor Using Copper Oxide and Gold Nanoparticles Decorated
Biosens. Bioelectron. 2020, 168,
112557.
Front.
Bioeng. Biotechnol. 2020, 8, 990.
https://t.me/med1917

432
Metals in Medicine, Volume 2
Colloids Surf. B 2021, 203, 111732.
Cancer Using Biomedicine. Biomed. Pharmacother. 2020, 132, 110878.
Graphene Hydrogel Nanocomposite and Redox Probes Labeled Aptamers. Sens.
Actuators B 2021, 332, 129515.
Biosens. Bioelectron. 2021, 174, 112831.
New J. Chem. 2021, 45 (15), 6960–6967.
Lasers Med. Sci.
2022, 37 (2), 1333–1341.
Arabian J. Chem. 2021, 14 (2),
102931.
Turbinaria
decurrensJ. Drug
Delivery Sci. Technol. 2022, 67, 103005.
Applications. J. Saudi Chem. Soc. 2022, 26 (2), 101419.
Caenorhabditis elegans to Gold Nanoparticles. Environ. Sci.
Technol. 2012, 46 (7), 4115–4124.
Agents: Physicochemical Characteristics and Applications in MR Imaging. Eur. Radiol.
2001, 11 (11), 2319–2331.
Labeling and Multicolor Optical Encoding. J. Biomed. Opt. 2002, 7 (4), 532–537.
Bubbles. Cardiovasc. Res. 2009, 83 (4), 615–616.
Spatially Addressable Parallel Chemical Synthesis. Science 1991, 251 (4995), 767–773.
PCR-Like Sensitivity. J. Am. Chem. Soc. 2004, 126 (19), 5932–5933.
https://t.me/med1917

Role of Gold Nanoparticles as Novel Agents for Cancer Diagnosis and Therapy
433
Controlled Drug-Delivery Devices. Angew. Chem. Int. Ed. 2000, 39 (14), 2396–2407.
in Biology and Biochemistry. Annu. Rev. Biomed. Eng. 2001, 3 (1), 335–373.
Nat. Biotechnol. 2003, 21 (10), 1184–1191.
in a Mesoporous Silicon Double Layer. Nat. Nanotechnol. 2009, 4 (4), 255–258.
Curr. Opin. Chem. Biol. 2006, 10
(1), 11–19.
Biological Media. J. Am. Chem. Soc. 2003, 125 (34), 10192–10193.
Science 2001, 293 (5533),
1289–3292.
Proc. Natl.
Acad. Sci. 2005, 102 (9), 3208–3212.
Curr. Opin. Genet. Dev. 2008, 18 (1),
68–72.
Biosens.
Bioelectron. 2009, 25 (4), 820–825.
Rev. Recent Clin. Trials. 2007, 2 (2), 121–134.
Biosens. Bioelectron. 2009, 24 (6), 1801–1805.
Biomarker. Anal. Chem. 2009, 81 (6), 2168–2175.
Nat. Biotechnol. 2005, 23
(10), 1294–1301.
Annu. Rev.
Biomed. Eng. 1999, 1 (1), 241–263.
J. Control. Release 2001, 74 (1–3), 7–25.
Nat.
Med. 1998, 4 (6), 655–657.
Promise and Current Progress. Proc. IEEE 2007, 95 (7).
https://t.me/med1917
Соседние файлы в папке Библиотека им академика М.И. Перельмана
